SourceBio International PLC Investor Presentation

TIDMSBI

SourceBio International PLC

09 November 2020

SourceBio International plc

("SourceBio", the "Company" or the "Group")

Investor Presentation

SourceBio International plc (AIM: SBI), a leading international provider of integrated state-of-the-art laboratory services and products, announces that it will be hosting a live online presentation open to all investors on Thursday 12 November at 4.30pm, delivered by Jay LeCoque, Executive Chairman, Tony Ratcliffe, CFO and Russell Wheatcroft, COO.

The Company is committed to providing an opportunity for all existing and potential investors to hear directly from management on its recent admission to AIM and provide an overview of the Company and its four main areas of focus, including the significant Covid-19 testing opportunity.

The presentation will be hosted through the digital platform Investor Meet Company. Investors can sign up to Investor Meet Company for free and add to meet SourceBio International plc via the following link:

https://www.investormeetcompany.com/sourcebio-international-plc/register-investor

For those investors who have already registered and added to meet the Company, they will automatically be invited.

Questions can be submitted pre-event via your IMC dashboard or in real time during the presentation, via the "Ask a Question" function. Whilst the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market through regulatory notifications. A recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards.

Contacts:

 
 SourceBio International plc                           www.sourcebiointernational.com 
 Jay LeCoque, Executive Chairman                                      Via Walbrook PR 
 Tony Ratcliffe, Chief Financial Officer 
 
 Walbrook PR Limited                   Tel: 020 7933 8780 or sourcebio@walbrookpr.com 
 Paul McManus                                                      Mob: 07980 541 893 
 Sam Allen                                                         Mob: 07748 651 727

About SourceBio International plc ( www.sourcebiointernational.com )

SourceBio is a leading international provider of integrated state-of-the-art laboratory services and products clients in the healthcare, clinical, life science research and biopharma industries, with a focus on improving patient diagnosis, management and care. Group revenues are derived from four core businesses areas:

-- Healthcare Diagnostics - histopathology and clinical diagnostic services for the NHS and private healthcare across the UK and Ireland;

-- Genomics - DNA sequencing services for pharmaceutical and biotechnology companies, academia, contract research organisations (CROs) and other research groups in the UK, Europe and North America;

-- Stability Storage - shelf life testing services and equipment for pharmaceutical and biotechnology companies, contract manufacturers and analytical testing companies from around the world but primarily in the UK, Ireland and the USA; and

-- Infectious Disease Testing - since May 2020, the Group has provided COVID-19 Antigen RT-PCR testing services. These services passed all of the auditing requirements of the NHS and the Department of Health and Social Care (DHSC) in April 2020. It is intended that this offering will potentially provide a broad range of infectious disease testing across the NHS, private healthcare and commercial sectors in the future.

More details on Group operations can be found here: www.sourcebioscience.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRABFBATMTMMBJM

(END) Dow Jones Newswires

November 09, 2020 02:00 ET (07:00 GMT)

Sourcebio (LSE:SBI)
Historical Stock Chart
From Sep 2024 to Oct 2024